JPRN-jRCT2080220743
Unknown
Phase 3
DU-176b Phase III Clinical Study (Venous Thromboembolism) Randomized Double-Blind Study of DU-176b in Patients Undergoing Total Hip Arthroplasty with Enoxaparin as an Active Control
DAIICHISANKYO Co.,Ltd.0 sites600 target enrollmentJune 9, 2009
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- DAIICHISANKYO Co.,Ltd.
- Enrollment
- 600
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients undergoing unilateral total hip arthroplasty
Exclusion Criteria
- •\-Subjects with risks of hemorrhage
- •\-Subjects with thromboembolic risks
- •\-Subjects who weigh less than 40 kg
- •\-Subjects who are pregnant or suspect pregnancy, or subjects who want to become pregnant
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 3
DU-176b Phase III Clinical Study (Venous Thromboembolism) -A multicenter, Randomized, Unblinded Study of DU-176b in Patients Undergoing Hip Fracture Surgery with Enoxaparin as a referencePatients undergoing hip fracture surgeryJPRN-jRCT2080220770DAIICHISANKYO Co.,Ltd.90
Unknown
Phase 3
DU-176b Phase 3 Clinical Study (Venous Thromboembolism) -Randomized Double-Blind Study of DU-176b in Patients Undergoing Total Knee Arthroplasty with Enoxaparin as an Active ControlJPRN-jRCT2080220701DAIICHISANKYO Co.,Ltd.520
Unknown
Phase 2
DU-176b Phase IIb clinical study (venous thromboembolism): Japan-Taiwan multicenter randomized double-blind dose-finding study using Enoxaparin as a reference in patients undergoing total hip replacementPatients undergoing total hip arthroplastyJPRN-jRCT2080220798DAIICHISANKYO Co.,Ltd.210
Unknown
Phase 2
DU-176b Phase IIb Clinical Study (Deep Vein Thrombosis)JPRN-jRCT2080220278DAIICHISANKYO Co.,Ltd.500
Unknown
Phase 2
Phase III Clinical Study of DU-176b (non-valvular atrial fibrillation): Japanese, Multicenter, Open-label Study of DU-176b in Patients with non-valvular atrial fibrillation and Severe Renal Impairmenton-valvular atrial fibrillationJPRN-jRCT2080221674DAIICHI SANKYO Co.,Ltd.90